Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 51,750 shares at $452.09 ($18.8M) on 2025-11-10, disclosed to the SEC on 2025-11-12.
Scheduled sale ($18.8M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.42 | 14,625 | $2.0M | 10.6% |
| 2 | $452.04 | 7,875 | $3.6M | 19.0% |
| 3 | $452.09 | 14,625 | $6.6M | 35.2% |
| 4 | $452.09 | 14,625 | $6.6M | 35.2% |
| Total | $362.59 avg | 51,750 | $18.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |